Work

FDA approves first-in-class drug for schizophrenia

Year: 2024

Type: other

Source: C&EN Global Enterprise

DOI: 10.1021/cen-10231-buscon2

Author: Sarah Braner

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403185173

Cites:

Cited by:

Related to: 10